Santiago R Leal-Noval1, Ángela Muñoz-Serrano2, Victoria Arellano-Orden3, Aurelio Cayuela4, Manuel Muñoz-Gómez5, Antonio Recio6, Antonio Alcántara3, Rosario Amaya-Villar3, Manuel Casado-Méndez3, Francisco Murillo-Cabezas3. 1. Critical Care Division, Instituto de Biomedicina IBIS, Hospital Universitario ''Virgen del Rocío'', Avda/Manuel Siurot, s/n, 41013, Seville, Spain. srlealnoval@gmail.com. 2. Neuropsychology Division, Instituto de Biomedicina IBIS, Hospital Universitario ''Virgen del Rocío'', Seville, Spain. 3. Critical Care Division, Instituto de Biomedicina IBIS, Hospital Universitario ''Virgen del Rocío'', Avda/Manuel Siurot, s/n, 41013, Seville, Spain. 4. Statistics and Design Division, Hospital de Valme, Seville, Spain. 5. Perioperative Transfusion Medicine, University of Málaga, Málaga, Spain. 6. Transfusion Service, Hospital Universitario ''Virgen del Rocío'', Seville, Spain.
Abstract
BACKGROUND: This 3-year prospective study examined the association between red blood cell transfusion (RBCT) and 1-year neurocognitive and disability levels in 309 patients with traumatic brain injury (TBI) admitted to the neurological intensive care unit (NICU). METHODS: Using a telephone interview-based survey, functional outcomes were assessed by the Glasgow Outcome Scale (GOS), Rancho Los Amigos Levels of Cognitive Functioning Scale (RLCFS), and Disability Rating Scale (DRS) and dichotomized as favorable and unfavorable (dependent variable). The adjusted influence of RBCT on unfavorable results was assessed by conventional logistic regression, controlling for illness severity and propensity score (introduced as a continuous variable and by propensity score-matched patients). RESULTS: Overall, 164 (53 %) patients received ≥1 unit of RBCT during their NICU stay. One year postinjury, transfused patients exhibited significantly higher unfavorable GOS (46.0 vs. 22.0 %), RLCFS (37.4 vs. 15.4 %), and DRS (39.6 vs. 18.7 %) scores than nontransfused patients. Although transfused patients were more severely ill upon admission, their adjusted odds ratios (95 % confidence intervals) for unfavorable GOS, RLCFS, and DRS scores were 2.5 (1.2-5.1), 3.0 (1.4-6.3), and 2.3 (1.1-4.8), respectively. These odds ratios remained largely unmodified when the calculated propensity score was incorporated as an independent continuous variable into the multivariate analysis. Furthermore, in 76 pairs of propensity score-matched patients, the rate of an unfavorable RLCFS score at the 1-year (but not 6-month) follow-up was significantly higher in transfused than nontransfused patients [3.0 (1.1-8.2)]. CONCLUSION: Our results strongly suggest an independent association between RBCT and unfavorable long-term functional outcomes of patients with TBI.
BACKGROUND: This 3-year prospective study examined the association between red blood cell transfusion (RBCT) and 1-year neurocognitive and disability levels in 309 patients with traumatic brain injury (TBI) admitted to the neurological intensive care unit (NICU). METHODS: Using a telephone interview-based survey, functional outcomes were assessed by the Glasgow Outcome Scale (GOS), Rancho Los Amigos Levels of Cognitive Functioning Scale (RLCFS), and Disability Rating Scale (DRS) and dichotomized as favorable and unfavorable (dependent variable). The adjusted influence of RBCT on unfavorable results was assessed by conventional logistic regression, controlling for illness severity and propensity score (introduced as a continuous variable and by propensity score-matched patients). RESULTS: Overall, 164 (53 %) patients received ≥1 unit of RBCT during their NICU stay. One year postinjury, transfused patients exhibited significantly higher unfavorable GOS (46.0 vs. 22.0 %), RLCFS (37.4 vs. 15.4 %), and DRS (39.6 vs. 18.7 %) scores than nontransfused patients. Although transfused patients were more severely ill upon admission, their adjusted odds ratios (95 % confidence intervals) for unfavorable GOS, RLCFS, and DRS scores were 2.5 (1.2-5.1), 3.0 (1.4-6.3), and 2.3 (1.1-4.8), respectively. These odds ratios remained largely unmodified when the calculated propensity score was incorporated as an independent continuous variable into the multivariate analysis. Furthermore, in 76 pairs of propensity score-matched patients, the rate of an unfavorable RLCFS score at the 1-year (but not 6-month) follow-up was significantly higher in transfused than nontransfused patients [3.0 (1.1-8.2)]. CONCLUSION: Our results strongly suggest an independent association between RBCT and unfavorable long-term functional outcomes of patients with TBI.
Authors: Santiago Ramón Leal-Noval; María Dolores Rincón-Ferrari; Ana Marin-Niebla; Aurelio Cayuela; Victoria Arellano-Orden; Antonio Marín-Caballos; Rosario Amaya-Villar; Carmen Ferrándiz-Millón; Francisco Murillo-Cabeza Journal: Intensive Care Med Date: 2006-09-22 Impact factor: 17.440
Authors: Dae Won Park; Byung-Chul Chun; Soon-Sun Kwon; Young Kyung Yoon; Won Suk Choi; Jang Wook Sohn; Kyong Ran Peck; Yang Soo Kim; Young Hwa Choi; Jun Yong Choi; Sang Il Kim; Joong Sik Eom; Hyo Youl Kim; Hee Jin Cheong; Young Goo Song; Hee Jung Choi; June Myung Kim; Min Ja Kim Journal: Crit Care Med Date: 2012-12 Impact factor: 7.598
Authors: Matthew A Warner; Terence O'Keeffe; Premal Bhavsar; Rashmi Shringer; Carol Moore; Caryn Harper; Christopher J Madden; Ravi Sarode; Larry M Gentilello; Ramon Diaz-Arrastia Journal: J Neurosurg Date: 2010-09 Impact factor: 5.115
Authors: Victor G Coronado; Lisa C McGuire; Kelly Sarmiento; Jeneita Bell; Michael R Lionbarger; Christopher D Jones; Andrew I Geller; Nayla Khoury; Likang Xu Journal: J Safety Res Date: 2012-08-25
Authors: Mypinder S Sekhon; Donald E Griesdale; Marek Czosnyka; Joseph Donnelly; Xia Liu; Marcel J Aries; Chiara Robba; Andrea Lavinio; David K Menon; Peter Smielewski; Arun K Gupta Journal: Neurocrit Care Date: 2015-10 Impact factor: 3.210
Authors: Ewout W Steyerberg; Nino Mushkudiani; Pablo Perel; Isabella Butcher; Juan Lu; Gillian S McHugh; Gordon D Murray; Anthony Marmarou; Ian Roberts; J Dik F Habbema; Andrew I R Maas Journal: PLoS Med Date: 2008-08-05 Impact factor: 11.069